Amylyx Pharmaceuticals Share Price Today
(NASDAQ: AMLX)

Name: Amylyx Pharmaceuticals Share Price Today (NASDAQ: AMLX) - Amylyx Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Amylyx Pharmaceuticals share price is $3.98 & ₹340.15 as on 18 Apr 2025, 2.30 'hrs' IST

$3.98

▲

0.16

(4.19%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Amylyx Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Amylyx Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Amylyx Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Amylyx Pharmaceuticals share price movements

Today's Low: $3.80
Today's High: $4.11
$3.98
4.52%
Downside
Day's Volatility :7.43%
Upside
3.05%
52 Weeks Low: $1.58
52 Weeks High: $7.27
$3.98
60.43%
Downside
52 Weeks Volatility :78.34%
Upside
45.25%

Amylyx Pharmaceuticals (AMLX) Returns

Period	Amylyx Pharmaceuticals, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	15.36%	-2.8%	0.0%
6 Months	-14.59%	-11.0%	0.0%
1 Year	112.83%	-1.9%	0.0%
3 Years	-59.92%	-1.5%	-12.9%

Amylyx Pharmaceuticals (AMLX) Key Statistics

in dollars & INR

Previous Close	$3.82
Open	$3.83
Today's High	$4.105
Today's Low	$3.8
Market Capitalization	$338.5M
Today's Volume	$724.3K
52 Week High	$7.27
52 Week Low	$1.575
Revenue TTM	$87.4M
EBITDA	$-291.0M
Earnings Per Share (EPS)	$-4.43
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-100.88%

How to invest in Amylyx Pharmaceuticals Stock (AMLX) from India?

It is very easy for Indian residents to invest directly in Amylyx Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Amylyx Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Amylyx Pharmaceuticals or AMLX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Amylyx Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Amylyx Pharmaceuticals shares which would translate to 0.215 fractional shares of Amylyx Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Amylyx Pharmaceuticals, in just a few clicks!

Returns in Amylyx Pharmaceuticals (AMLX) for Indian investors in Rupees

The Amylyx Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Amylyx Pharmaceuticals investment value today

Current value as on today

₹2,15,175

Returns

₹1,15,175

(+115.18%)

Returns from Amylyx Pharmaceuticals Stock

₹1,12,834 (+112.83%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Amylyx Pharmaceuticals (AMLX)

63%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Amylyx Pharmaceuticals Stock from India on INDmoney has increased by 63% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Amylyx Pharmaceuticals

Perceptive Advisors LLC
7.65%
TCG Crossover Management, LLC
5.24%
Vanguard Group Inc
3.04%
Bank of America Corp
2.74%
BlackRock Inc
2.57%
Almitas Capital LLC
2.29%

Analyst Recommendation on Amylyx Pharmaceuticals

Rating

Trend

Buy

53%Buy

46%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Amylyx Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Amylyx Pharmaceuticals Stock (AMLX)

What analysts predicted

Upside of 121.11%

Target:

$8.80

Current:

$3.98

Insights on Amylyx Pharmaceuticals Stock (Ticker Symbol: AMLX)

Price Movement
In the last 1 month, AMLX stock has moved up by 4.7%
Decreasing Revenue
Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -72.70M → -37.54M (in $), with an average increase of 93.6% per quarter
AMLX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 93.5%

Amylyx Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Amylyx Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Amylyx Pharmaceuticals (AMLX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Amylyx Pharmaceuticals, Inc.	2.41%	-14.59%	112.83%	-59.92%	-77.97%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Amylyx Pharmaceuticals, Inc.	2.51	NA	NA	-1.88	-1.01	-0.51	NA	2.4
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Amylyx Pharmaceuticals, Inc.	Buy	$338.5M	-77.97%	2.51	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Organization	Amylyx Pharmaceuticals
Employees	123
CEO	Mr. Justin B. Klee
Industry	Services

Management People of Amylyx Pharmaceuticals

Name	Title
Mr. Joshua B. Cohen	Co-Founder, Co-CEO & Director
Mr. Justin B. Klee	Co-Founder, Co-CEO & Director
Mr. James M. Frates M.B.A.	Chief Financial Officer
Ms. Gina M. Mazzariello J.D.	Chief Legal Officer & General Counsel
Dr. Camille L. Bedrosian M.D.	Chief Medical Officer
Mr. Tom Holmes	Chief Technical Operations Officer
Ms. Lindsey Allen	Head of Investor Relations & Communications
Ms. Linda A. Arsenault	Chief Human Resources Officer
Ms. Tammy Sarnelli	Global Head of Regulatory Affairs
Dr. Machelle Manuel Ph.D.	VP & Head of Global Medical Affairs

Important FAQs about investing in AMLX Stock from India :

What is Amylyx Pharmaceuticals share price today?

Amylyx Pharmaceuticals share price today stands at $3.98, Open: $3.83 ; Previous Close: $3.82 ; High: $4.11 ; Low: $3.80 ; 52 Week High: $7.27 ; 52 Week Low: $1.58.

The stock opens at $3.83, after a previous close of $3.82. The stock reached a daily high of $4.11 and a low of $3.80, with a 52-week high of $7.27 and a 52-week low of $1.58.

Can Indians buy Amylyx Pharmaceuticals shares?

Yes, Indians can invest in the Amylyx Pharmaceuticals (AMLX) from India.

With INDmoney, you can buy Amylyx Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Amylyx Pharmaceuticals at zero transaction cost.

How can I buy Amylyx Pharmaceuticals shares from India?

It is very easy to buy Amylyx Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Amylyx Pharmaceuticals (AMLX) be purchased?

Yes, you can buy fractional shares of Amylyx Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Amylyx Pharmaceuticals stocks?

To start investing in Amylyx Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.